Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (360)	6/12/1998 12:28:00 PM
From: macker	Read Replies (2) \| Respond to of 5402

answer the question macker

To: Andrew H who wrote (360)	6/12/1998 12:31:00 PM
From: Dixie7777	Respond to of 5402

I believe that this was posted earlier in the thread. i know that i have read it, maybe on the edgar site. but that's old news. what date was that posted? Even if it was only last month things are about to happen to overwhelm that. the renewed interest is just because of that! SGNC is about to enter animal testing.

To: Andrew H who wrote (360)	6/12/1998 12:33:00 PM
From: Lee Walsh	Respond to of 5402

Andrew, I believe if you look in SEC filings for ALL Biotech companies in the R & D Stage, you will see the following. 1) Statements like you just posted. 2) Very little if any Revenues. That's just the nature of these type companies. I know this, I have had several of these type companies in the past.... But, if they get ANY good results, or any large Med. company to even peek at what they are doing....LOOK OUT!!! Lee

To: Andrew H who wrote (360)	6/12/1998 12:33:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

This is old new Andrew... If you continue to read futher Sanguine will start it's small animal testing soon,,, and the first deneration of this product was tested on 1,500 people with no side effects... come on Andrew keep diggin pretty soon you'll be on the positive side ..Hahahaha Prospector ( the deeper ya dig the better it gets)

To: Andrew H who wrote (360)	6/12/1998 12:33:00 PM
From: Hyrulean King	Respond to of 5402

Remember this is a biotech and this is how they operate before funding/backing. This is a fully reporting co and they must disclose risks that may affect stock price. I also believe (and will confirm) that this was released before funding was lined up. Chief

To: Andrew H who wrote (360)	6/12/1998 12:40:00 PM
From: drdan	Read Replies (1) \| Respond to of 5402

Andrew this is obviously true. But so what? How do you know that the company wont be starting animaltrials on Monday, or whenever? How do we know whether some company hasnt already promised Dr. Drees some money for research? Look, you have a drug here which is a derivative of a drug previously OK'ed by the FDA. There is a resonable chaNCE that this drug will be ok as well. Rather than cause concern, why not wait until I and others can get more info on this drug and company before you make posts such as this one. Try to be a bit open-minded until moreinfo is available.